Hims & Hers Health Newsroom

Hims & Hers Health Analyst Ratings

BenzingaJun 27 11:40 ET

Hims & Hers Health Analyst Ratings

BenzingaJun 13 12:10 ET

Hims & Hers Health Analyst Ratings

BenzingaJun 3 08:01 ET

Hims & Hers Health Analyst Ratings

BenzingaMay 22 08:37 ET

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Hims & Hers Health (HIMS) and Cytokinetics (CYTK)

TipRanksMay 22 00:55 ET

Hims & Hers Health's Strategic Growth in Weight Loss Market Warrants Buy Rating Despite Regulatory Risks

TipRanksMay 20 10:50 ET

Deutsche Bank Adjusts Hims & Hers Health Price Target to $16 From $14, Maintains Hold Rating

MT NewswiresMay 7 08:37 ET

Buy Rating Affirmed for Hims & Hers Health Amidst Strong Quarterly Performance and Positive Outlook

TipRanksMay 7 07:55 ET

Hims & Hers Health Analyst Ratings

BenzingaMay 7 07:21 ET

Hims & Hers Health Analyst Ratings

BenzingaApr 16 06:48 ET

Hims & Hers Health Analyst Ratings

BenzingaApr 10 07:51 ET

Hims & Hers Health Outperforms: Strong Sales Growth and Brand Value Reinforce Buy Rating

TipRanksApr 10 06:20 ET

Analysts Offer Insights on Healthcare Companies: Regulus (RGLS), Hims & Hers Health (HIMS) and Olink Holding (OLK)

TipRanksMar 27 03:08 ET

Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating

MT NewswiresMar 1 06:59 ET

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Hims & Hers Health (HIMS) and Amylyx Pharmaceuticals Inc (AMLX)

TipRanksFeb 28 00:01 ET

Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating

MT NewswiresFeb 27 10:30 ET

Hims & Hers Health Analyst Ratings

BenzingaFeb 27 08:56 ET

Analysts Are Bullish on Top Healthcare Stocks: Bruker (BRKR), Hims & Hers Health (HIMS)

TipRanksFeb 27 08:10 ET

Truist Financial Reaffirms Their Hold Rating on Hims & Hers Health (HIMS)

TipRanksFeb 27 07:48 ET

Hims & Hers Health (HIMS) Gets a Hold From Piper Sandler

TipRanksFeb 27 07:44 ET